MPH Nexora Pty Ltd is pleased to announce that the Murdoch Children's Research Institute (MCRI) — one of the world's leading child health research institutes — has formally onboarded to the MPH Nexora AI platform, with C-level executives completing the onboarding process on 9 April 2026 as part of its ever expanding testing cohort.
MCRI is headquartered at the Royal Children's Hospital in Melbourne and is globally recognised for its research into the prevention and treatment of childhood diseases. The institute's testing of the MPH Nexora platform marks a significant milestone in the company's institutional rollout strategy across Australia's medical research sector.
The onboarding of MCRI follows a series of recent institutional engagements, including the AAMRI quarterly briefing, and reinforces MPH Nexora's position as the platform for Australia's most respected research organisations.
"Murdoch Children's Research Institute represents exactly the kind of world-class institution that MPH Nexora was built to serve," said Nigel Blair, Founder and CEO of MPH Nexora. "Their commitment to translating research into better health outcomes for children globally aligns perfectly with our mission. We are proud to welcome MCRI to the platform and look forward to supporting and serving them in their important work."
